Adjuvant and neoadjuvant therapy in colorectal cancer

被引:0
|
作者
Jacobi, N. [1 ]
Gieseler, F. [1 ]
机构
[1] Univ Hosp Lubeck, Dept Internal Med, Hematol Oncol Sect, D-23538 Lubeck, Germany
来源
EUROPEAN SURGERY-ACTA CHIRURGICA AUSTRIACA | 2010年 / 42卷 / 06期
关键词
Colorectal cancer; adjuvant therapy; neoadjuvant therapy; III COLON-CANCER; PHASE-III; STAGE-II; PREOPERATIVE RADIOTHERAPY; RANDOMIZED-TRIAL; RECTAL-CANCER; FLUOROURACIL; LEUCOVORIN; CHEMOTHERAPY; OXALIPLATIN;
D O I
10.1007/s10353-010-0568-4
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background Like no other disease, colorectal cancer has become the poster child for optimal interdisciplinary collaboration of surgeons, medical oncologists and radiation therapists Methods In this article, we present the current state of the-art treatment of non metastatic colorectal cancer Results Since the implementation of adjuvant chemotherapy it ha become possible to significantly improve PFS and OS in locally advanced colon cancer Disease free survival, on the other hand, is considerably improved when treated with chemoradiation in a neoadjuvant fashion Conclusions The prognosis of colorectal cancer is dependent on a multidisciplinary approach employing state-of-the art adjuvant and neoadjuvant treatment
引用
收藏
页码:283 / 286
页数:4
相关论文
共 50 条
  • [31] Adjuvant Therapy Trials
    Ursem, Carling
    Van Loon, Katherine
    Venook, Alan
    CANCER JOURNAL, 2016, 22 (03) : 196 - 198
  • [32] SEOM clinical guidelines for the adjuvant treatment of colorectal cancer 2013
    Maurel, J.
    Gravalos, C.
    Rivera, F.
    Vera, R.
    Gonzalez Flores, E.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2013, 15 (12) : 991 - 995
  • [33] Integration of neoadjuvant and adjuvant chemotherapy in patients with resectable liver metastases from colorectal cancer
    Hebbar, Mohamed
    Pruvot, Francois-Rene
    Romano, Olivier
    Triboulet, Jean-Pierre
    de Gramont, Aimery
    CANCER TREATMENT REVIEWS, 2009, 35 (08) : 668 - 675
  • [34] Adjuvant Therapy in Colorectal Cancer: Aspirin, a Targeted Therapy?
    Sibertin-Blanc, C.
    Dahan, L.
    Michel, P.
    Seitz, J. -F.
    ONCOLOGIE, 2014, 16 (11-12) : S509 - S515
  • [35] Liposomal anthracyclines: Adjuvant and neoadjuvant therapy for breast cancer
    Campos, S
    ONCOLOGIST, 2003, 8 : 10 - 16
  • [36] Adjuvant therapy of rectal cancer following neoadjuvant radiochemotherapy
    Kuetting, Fabian
    Alakus, Hakan
    Bruns, Christiane
    ONKOLOGE, 2020, 26 (02): : 185 - 186
  • [37] Is there an indication for adjuvant or neoadjuvant systemic therapy in prostate cancer?
    Boergermann, C.
    Miller, K.
    vom Dorp, F.
    Jaeger, T.
    Ruebben, H.
    UROLOGE, 2007, 46 (10): : 1385 - +
  • [38] Economic evaluation of capecitabine as adjuvant or metastatic therapy in colorectal cancer
    Best, Jennie H.
    Garrison, Louis P., Jr.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2010, 10 (02) : 103 - 114
  • [39] Adjuvant and/or neoadjuvant therapy for gastric cancer? A perspective review
    Schirren, Rebekka
    Reim, Daniel
    Novotny, Alexander R.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2015, 7 (01) : 39 - 48
  • [40] Immune checkpoint inhibitor therapy in neoadjuvant and adjuvant treatment for cancer: A paradigm shift in the treatment of resectable gastrointestinal cancer 3)A paradigm shift in the treatment of colorectal cancer
    Oshima, Kotoe
    Yamazaki, Kentaro
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2023, 28 (11) : 1442 - 1450